Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Cells|July 26, 2024
Intake of Special Amino Acids Mixture Leads to Blunted Murine Colon Cancer Growth In Vitro and In VivoGiovanni Corsetti, Claudia Romano, Silvia Codenotti, et al.
Cancer Letters|February 17, 2019
Caveolin-1 enhances metastasis formation in a human model of embryonal rhabdomyosarcoma through Erk signaling cooperationSilvia Codenotti, Fiorella Faggi, Roberto Ronca, et al.
Clinical and Experimental Medicine|February 10, 2023
The modulation of iron metabolism affects the Rhabdomyosarcoma tumor growth in vitro and in vivoMichela Asperti, Luca Cantamessa, Magdalena Gryzik, et al.
Oncology Reports|May 23, 2015
Melatonin decreases cell proliferation, impairs myogenic differentiation and triggers apoptotic cell death in rhabdomyosarcoma cell linesSilvia Codenotti, Michela Battistelli, Sabrina Burattini, et al.
Cancer Drug Resistance (Alhambra, Calif.)|December 22, 2025
Disrupting resistance: novel therapeutic approaches to combat multidrug resistance in fusion-negative rhabdomyosarcomaSilvia Codenotti, Francesco Marampon, Francesca Megiorni, et al.
Biochimica Et Biophysica Acta. General Subjects|October 1, 2023
The D647N mutation of FGFR1 induces ligand-independent receptor activationMattia Domenichini, Cosetta Ravelli, Michela Corsini, et al.
Biomolecules|September 28, 2024
Phospholipase Cδ-4 (PLCδ4) Acts as a Nuclear Player to Influence Cyclin B Expression in the Embryonal Rhabdomyosarcoma Cell Lines RD and A204Sara Salucci, Alberto Bavelloni, Ilaria Versari, et al.
Molecular Pharmaceutics|April 13, 2026
Biotin-Decorated Inulin-Based Polymeric Micelles Unveil Their Dual-Targeting Ability for the Potential Treatment of Glioblastoma Multiforme through the <i>In Vitro</i> and <i>In Vivo</i> InvestigationsPaola Riccobelli, Elena Cannone, Serena Filiberti, et al.
Biochemical Pharmacology|September 9, 2025
Didox, a ribonucleotide reductase inhibitor with iron chelator properties, counteracts the in vitro and in vivo growth of rhabdomyosarcoma cellsLuca Cantamessa, Michela Asperti, Magdalena Gryzik, et al.
Frontiers in Oncology|October 17, 2022
Radioresistance in rhabdomyosarcomas: Much more than a question of doseSimona Camero, Matteo Cassandri, Silvia Pomella, et al.
Pageof 4